{"effective_time":"20190724","health_care_provider_letter":["Health Care Provider Letter Dear Healthcare Provider Letter - Image 01 Dear Healthcare Provider Letter updated_image 2 Dear Healthcare Provider Letter updated_image 3 Dear Healthcare Provider Letter updated_image 4 Dear Healthcare Provider Letter updated_image 5"],"id":"a91d98dd-e8b2-4d99-88d9-84802c5f1e4e","openfda":{},"package_label_principal_display_panel":["PACKAGE/LABEL PRINCIPAL DISPLAY PANEL BATCH EXP 5% DEXTROSE INJECTION 100mL VIAFLEX CLOSURE SYSTEM STORE AT ROOM TEMPERATURE (15°C TO 30°C) ADULT AND PEDIATRIC USE EACH 100ML CONTAINS DEXTROSE HYDROUS 5G WATER FOR INJECTION SUFFICIENT QUANTITY TO 100ML pH APPROX 4.0 OSMOLARITY APPROX 252 mOsml/L INTRAVENOUS ADMINISTRATION STERILE NONPYROGENIC SOLUTION DO NOT USE IF TURBIDITY IS PRESENT SINGLE USE DISCARD AFTER USE INFORMATION TO THE HEALTHCARE PROFESSIONAL INDICATIONS CONTRAINDICATIONS AND PRECAUTIONS REFER TO PACKAGE INSERT ALL MEDICINES SHOULD BE KEPT OUT OF THE REACH OF CHILDREN REMOVE THE OVERPOUCH FOR USE LATEX FREE PRODUCT RESTRICTED USE FOR HOSPITALS SALE UNDER MEDICAL PRESCRIPTION BAXTER BAXTER HOSPITALAR LTDA HENRI DUNANT STREET 1383 12º FLOOR TOWER B CONJ 1201 E 1204 SÃO PAULO SP BRAZIL CNPJ 49351786000180 BRAZILIAN INDUSTRY LICENSE NUMBER 1068300700282 TECHNICAL RESPONSIBLE: LUIZ GUSTAVO TANCSIK CRF 67982 CUSTOMER SERVICE 08000125522 BAXTER AND VIAFLEX ARE BRANDS OF BAXTER INTERNATIONAL INC PRINTED IN BRAZIL 25 50 75 28 25 01 499 FZB0087 Dextrose Drug Shortage Representative Label"],"set_id":"54869f91-4d0e-4b2c-a818-ab899a252934","spl_product_data_elements":["DEXTROSE dextrose monohydrate DEXTROSE MONOHYDRATE ANHYDROUS DEXTROSE WATER"],"version":"3"}